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1. Introduction 
A unique property of tubulin is to bind 
colchicine and colcemid, two structurally similar 
drugs, both of which disaggregate the polymerised 
form of this protein ]l-51. In spite of structural 
similarity, certain differences in mode of action for 
these ligands exist. Studies on mitotic arrest of 
different cells in culture with colchicine and cofcemid 
suggest a more rapid release of bound colcemid than 
of colchicine Et;]. Moreover, the response of yeast 
tubulin towards colcemid binding and not to 
colchieine [7]* led us to investigate he mechanism of
binding of these two structurally similar drugs to 
tub&n. Here we describe xperiments o show 
that binding kinetics of colchicine and colcemid to 
tubulin are very different. 
2, Materi& and methods 
Both colchicine and colcemid {ring C, [3H]me~oxy) 
having spec. act. .5 Ci/mmol and 9.3 Cilmmol, 
respectively, were products of New England Nuclear 
Corp. GTF (Grade IIS) and colchicine were products 
of Sigma. Colcemid was obtained from K and IL 
GF/C and DE 81 filter papers were products of 
Whatman. All other chemicals used were reagent 
grade. 
Tub&n was purified from goat brain according to 
[8] and stored at -10°C in PMG (IO mM phosphate 
(pH 7.0), 10 mM MgClz and 0.1 mM GTQ buffer 
containing 1 M sucrose. Protein was determ~ed 
bythe Lowry method [9] using bovine serum 
albumin as standard. 
2.1. Binding assay 
The DE 8 1 filter paper disc assay for colchicine 
[lo] had to be modified to make it suitable for 
colcemid binding. Whatman GF/C falter paper discs 
(one or more depending on the protein content) 
were washed with 1 ml cold (2-4°C) PM buffer 
(10 mM phosphate (pH 7 .O) and 10 mM MgCls) by 
suction, taking care not to dry the papers. The sample 
(0.1 ml) was applied and absorbed to the filters 
directly, over l-2 min. The filters were then rinsed 
3 times with 3 ml cold PM buffer by mild suction, 
dried and counted in toluene-based fluor. 
3. Results 
Preliminary experiments as shown in tabie 1 
suggest that ~~0~~ both colchicine and colcemid 
possess identical t~me~oxy phenyl and tropolone 
moieties, the DE 81 fifter disc assay for colchicine 
could not be used to study colcemid-tubuliri inter- 
action, We have therefore developed anew assay 
method to study colcemid-tubulin interaction using 
glass fibre ftiter paper which could be successfully 
used in the case of colchicine tubulin interaction too. 
Formation of colcemid-tubulin complex, detected 
by the new GF/C falter paper disc method described, 
is a linear function of protein concentration, as 
shown in fig.1. 
The rate of colchicine binding to tubulin is very 
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Table 1 
Colchicine and colcemid binding to tubulin as compared by DE 81 and GF/C 
filter disc methods 
Conditions % Total input radioactivity 
retained on filter papers 
-- 
DE81 GF/C 
[ ‘H JColchicine [ ‘H]Colcemid [ sH]Colchicine [ ‘H]Colcemid 
~- 
No Tubulin 0.8 4.0 0.75 1.0 
100 Tubulin pg 11.0 6.0 9.0 6.0 
Tubes were incubated with labelled drugs (1 PM) at 37°C for 1 h with and without 
tubulin 
slow and has high temperature coefficient. The 
binding requires long incubation at 37°C to reach the 
equilibrium [5]. Figure 2 shows that the binding of 
colchicine (1 PM) to tubulin required about 2 h to 
equilibrate at 37’C (fig2A), whereas, the binding 
of colcemid (1 PM) occurred at a much faster rate 
requiring only about 45 min to reach the equilibrium 
(fig.2B). It may also be noted from the figure that at 
time zero, [3H]colchicine did not bind tubulin at all, 
but [3H]colcemid binding occurred to -40% of its 
total value. 
TUBULIN ()rg) 
Fig.1. Linearity of the CF/C filter disc assay for the colcemid- 
tubulin binding reaction. [‘H]Colcemid (1 X 10m6 M) was 
incubated with increasing concentration of tubulin in 
PMG buffer (pH 7.0) for 45 min at 37°C. 
60 120 160 
TIME (minutes 1 
Fig.2. Time dependence for the binding of [ ‘Hlcolchicine 
and [‘Hlcolcemid to tubulin. Tubulin (0.7 mg/ml) was 
incubated with (A) [3H]colchicine (1 PM) and (B) 
[ ‘Hlcolcemid (1 PM) at 37°C. At the times indicated aliquots 
from each tube were removed and assayed for the bound 
radioactivity by the GF/C filter disc method as described. 
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Table 2 
Effect of excess m&belled colcemid and colchicine 
on their respective complexes with tubulin 
Incubation period 
after addition of 
unlabelled drug (min) 
% Initial binding remaining 
---I_~ 
Colcemid Colchicine 
0 100 100 
10 66.3 96.6 
20 55.1 90.4 
30 42.1 92.6 
60 34.2 87.9 
120 27.3 82.8 
Tubulin (0.7 mgjml) was incubated with [ 3H]colcemid 
(1 PM) and [ ‘HJcolchicine (1 PM) separately for 1 h at 
37°C. Appropriate amounts of unlabelled drugs were added 
to the respective tubes to make 1 X 10m4 M ligand final cont. 
and incubated further at 37’C. At indicated periods of time 
aliquots were taken and assayed using GF/C filter paper 
method as described 
Another important difference in the binding of 
these two ligands to tubulin is that, while one is 
almost irreversible the other one is freely reversible. 
Table 2 shows that when an excess of unlabelled 
colcemid (1 X 10e4 M) is added to tubulin that has 
been preincubated with [3H]colcemid (1 PM) and is 
incubated further, -66% of the total initial bound 
radioactivity is displaced within 1 h. In contrast, the 
initial radioactivity bound to tubulin in a parallel 
experiment with [3H]coIchicine (1 PM) remains 
largely unaffected upon the addition of 1 X 10e4 M 
unlabelled colchicine. This suggests that unlike 
colchicine, the binding of colcemid to tubulin is 
highly reversible. 
So far we have furnished evidence to show that 
the binding of colcemid to tubulin differs from that 
of colchicine with respect to rapid equilibration, 
time zero binding and finally, reversibility. Next, we 
examined the effect of colcemid on the colchicine 
binding site of tubulin as analysed by modified Dixon 
plot. Figure 3 shows that the [3H]colchicine binding 
is inhibited competitively by colcemid yielding an 
app. KI 6.5 X 10m6 M. Thus, although the mechanism 
of colcemid binding to tubulin differs from that of 
colchicine, both the drugs appear to bind tubulin at 
the same binding site. 
m 
a 
-20 -IO 0 IO 20 
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Fig.3. Modified Dixon plot demonstrating the effect of 
colcemid on the colchicine binding to tubulin. The con- 
centration of colcemid present is plotted against he reciprocal 
of the bound [ ‘H]colchicine at several concentrations of 
[‘Hjcolchicine: (e) 1 PM; (A) 2 yM; (0) 4 &M. The reaction 
mixtures containing tubufin (0.2 m~ml) and the drugs as 
indicated were incubated at 37°C for 90 min and binding was 
assayed by the GF/C filter disc method as described. 
4. Conclusion 
Here we have confirmed the conclusion that 
colcemid is a competitive inhibitor for colchicine 
binding to tubulin. However, the two binding 
processes were found to be very different in the 
following properties: 
{i) Colchicine binds tub&n slowly and requires 
2 h to attain equ~ibrium at 37”C, whereas, 
colcemid binds more rapidly and equilibrium 
is attained within 4.5 min; 
(ii) In contrast to colchicine-tubulin interaction, 
which is almost irreversible, the binding of 
colcemid to tubulin is freely reversible; 
(iii) Moreover, though colchicine does not bind 
tubulin at O”C, there is substantial binding of 
colcemid to tubulin at this temperature. 
These differences made it difficult to envisage a 
single mechanism for the apparent competition 
between these two ligands for the same binding site. 
Whether these imply that the mechanism of binding 
reaction of these two ligands to the same site of 
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tubulin will be determined by the substituents in 
the B-ring remains to be settled. 
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